Summary & Overview
HCPCS Level II H0020: Methadone Administration and Program Provision
HCPCS Level II code H0020 designates methadone administration and program-based provision of the drug as part of substance use disorder treatment. Nationally, this code is central to opioid use disorder treatment programs that provide medication-assisted treatment (MAT) on-site, distinguishing services where the licensed program dispenses methadone directly to patients. Its correct use affects coverage determinations, claims processing, and reporting for behavioral health providers and treatment programs.
Major commercial payers reviewed include Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare. Readers will learn how H0020 is defined clinically and administratively, how it interacts with related behavioral health service codes, and the common billing contexts in which it appears. The publication covers typical places of service, common clinical indications, and associated service lines to clarify coding choices for encounters involving program-managed methadone dispensing.
The report provides baseline benchmarks for code usage, notes common documentation elements and claim line structure, and summarizes policy considerations affecting reimbursement and program compliance. Where input data are missing, the publication states those gaps explicitly. This summary is written for national stakeholders including clinicians, billing professionals, and payers seeking clear guidance on the role of HCPCS Level II code H0020 in medication-assisted treatment workflows.
Billing Code Overview
HCPCS Level II code H0020 covers alcohol and/or drug services for methadone administration and/or service, where the provision of the medication is handled by a licensed program. This code is used for services delivered as part of behavioral health and substance use disorder treatment.
Typical site of service is a Community Mental Health Center (POS 53).
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A patient with opioid use disorder presents to a Community Mental Health Center (POS 53) seeking medication-assisted treatment. Intake includes an assessment, verification of medical history, and establishment of a treatment plan. A licensed program provides supervised methadone dosing during the visit; nursing staff prepare and administer the methadone under program protocols. Documentation includes the dose given, time of administration, patient response, and any counseling or monitoring provided during the encounter. Billing uses HCPCS Level II code H0020 for the methadone administration and/or service (provision of the drug by a licensed program).
Coding Specifications
-
Common modifiers:
-
HF: Indicates the service was provided through a Substance Abuse Program. Use when the treating facility or program is recognized as a substance abuse program. -
U1: Indicates Medicaid Level of Care 1. Use when the patient’s Medicaid authorization or program-level billing requires designation of Level of Care 1. -
Associated provider taxonomies and specialties:
-
101YA0400X— Addiction (Substance Use Disorder) Counselor: Behavioral health provider focusing on counseling and case management for substance use disorders. -
103TP2701X— Psychologist, Addiction (Substance Use Disorder): Psychologist specializing in assessment and psychotherapy for substance use disorders. -
2084P0800X— Psychiatry & Neurology, Addiction Psychiatry: Physician specialty focused on medical management and psychiatric care for addiction.
Related Diagnoses
F11.20— Opioid dependence, uncomplicated
Clinical relevance: This diagnosis commonly indicates ongoing opioid dependence for which methadone maintenance therapy (billed with HCPCS Level II code H0020) is an evidence-based treatment option.
F11.220— Opioid dependence with intoxication, uncomplicated
Clinical relevance: This code indicates intoxication related to opioid dependence; methadone administration may be part of treatment planning once stabilized and during ongoing maintenance.
F11.221— Opioid dependence with intoxication delirium
Clinical relevance: This code indicates intoxication with delirium; acute medical stabilization is prioritized, and subsequent methadone administration in a licensed program may occur as part of ongoing treatment once clinically appropriate.
Related Codes
-
H0001— Alcohol and/or drug assessment -
H0004— Behavioral health counseling and therapy -
H0038— Self-help/peer services, per 15 minutes -
H0047— Alcohol and/or other drug abuse services, not otherwise specified -
Relationship to
HCPCS Level II code H0020: -
H0001is typically completed at intake to document the alcohol and/or drug assessment that precedes initiation of methadone treatment; often billed separately from methadone administration. -
H0004documents counseling or therapy provided during or as part of the visit where medication is administered; may be billed in addition to methadone administration when separate counseling services are delivered. -
H0038documents peer support or self-help services provided in conjunction with medication treatment; may be billed in 15-minute units alongside medication services when applicable. -
H0047is used for alcohol or other drug abuse services that do not fit other specified codes and may be used as an adjunct or alternative billing code when services provided do not meet other code descriptions. -
Common usage notes:
H0001andH0004are commonly used together withHCPCS Level II code H0020in the clinical workflow for patients initiating and continuing methadone treatment.H0038andH0047may be used alongside or as alternatives depending on the specific services delivered.
National Reimbursement Benchmarks
National mean rates for HCPCS Level II code H0020 show a large spread between Medicare-equivalent values and commercial payors. BUCA (average commercial) mean rate of $28.29 is substantially lower than UnitedHealthcare at $259.58, while Aetna ($23.25), Blue Cross Blue Shield ($29.65), and Cigna Health ($17.92) cluster in the low-to-mid $20s. Medicare is not provided in the input and is shown as $0.00 for reference.
Rate dispersion measured as the difference between the 75th and 25th percentiles varies notably across payors. UnitedHealthcare exhibits the widest dispersion (261 - 236 = $25.00), while Aetna and Cigna Health are the tightest with no dispersion (both have P75 = P25). Blue Cross Blue Shield and BUCA show moderate dispersion (Blue Cross Blue Shield: $24.00 - $13.11 = $10.89; BUCA: $24.00 - $13.00 = $11.00). The table and chart below present the full breakdown.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.